Thompson et al., 2010, using an allogeneic model of donor p19-/-mouse, have demonstrated that p19 deficiency in allogeneic donor transplantation reduces acute GVHD severity, but increases IL-17 mRNA and serum levels. This evidence concerns the gene IL17A and acute graft versus host disease.